A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Insulin 320 in Healthy Subjects

NCT02479022 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2
Healthy

Interventions

DRUG: Insulin 320
DRUG: insulin glargine
DRUG: placebo

Sponsor

Novo Nordisk A/S